The Antibiotic Resistance Rates in Multidrug Resistant Acinetobacter Isolates from Microbiological Culture Samples of Adult Patients in Turkey: A Retrospective Study

Objective: Acinetobacter species lead to extremely serious infections, particularly in hospitalized patients, and patients with impaired host defense. The high rates of resistance against several antibiotics detected recent years have created issues treatments different diseases. We aimed examine antibiotic profiles isolated from who are treated as outpatients polyclinics or services intensive care units (ICU), various antimicrobial therapies.
 Materials Methods: Antibiotic strains 533 clinical samples collected between 2017-2021 Bandırma State Hospital Clinical Microbiology Laboratory were evaluated retrospectively. identification isolates susceptibility tests performed by BD Phoenix (Becton Dickinson, USA) automated system.
 Results: Most respiratory secretions (32.5%) urine (24.4%). Of species, 63.8% baumannii, 34.9% baumannii complex, 1.1% other spp., 0.2% lwoffii. Resistance found following: ciprofloxacin 91.1%, meropenem 91.3%, imipenem 89.2%, gentamicin 82.5%, trimethoprim-sulfamethaxasol 78.6%, amikacin 66.3% (highest 2020), aztreonam 99.0% (significantly decreased ceftriaxone 100%, ampicillin amoxicillin-clavulanate ertapenemicin cefuroxime netilmicin 62.5%, nitrofurantion colistin 4.7% levofloxacin 87.1%. service ICU more resistant Ciprofloxacin, Levofloxacin, Meropenem, Imipenem, Trimethoprim/Sulfamethoxazole, Gentamicin Amikacin (P